Inventor · disambiguated record
Robert A. Galemmo, Jr.
Also filed as: GALEMMO JR ROBERT · GALEMMO JR ROBERT A · GALEMMO JR ROBERT ANTHONY · GALEMMO ROBERT
47 granted patents·17 pending applications·1,168 citations·filing 1987–2024
98Inventor score
Files withRHONE POULENC RORER PHARMA7RORER PHARMACEUTICAL CORP7CORTEXYME INC6DU PONT PHARM CO4JANSSEN PHARMACEUTICA NV4
Top patents by PatentIndex Score
64 records- 0198US5998424AInhibitors of factor Xa with a neutral P1 specificity groupDU PONT PHARM CO·Filed 1998·Granted Dec 7, 1999·163 cites·23 claims
- 0297US6602895B2Inhibitors of factor Xa with a neutral P1 specificity groupBRISTOL MYERS SQUIBB CO·Filed 2002·Granted Aug 5, 2003·80 cites·18 claims
- 0397US6548525B2Nitrogen containing heteroaromatics with ortho-substituted P1's as factor Xa inhibitorsBRISTOL MYERS SQUIBB PHARMA CO·Filed 2001·Granted Apr 15, 2003·125 cites·17 claims
- 0496US6403620B1Inhibitors of factor Xa with a neutral P1 specificity groupFiled 1999·Granted Jun 11, 2002·91 cites·15 claims
- 0596US4920131AQuinoline derivatives and use thereof as antagonists of leukotriene D4RORER PHARMACEUTICAL CORP·Filed 1988·Granted Apr 24, 1990·73 cites·19 claims
- 0695US4918081AQuinoline derivatives and use thereof as antagonists of leukotriene d4RORER PHARMACEUTICAL CORP·Filed 1988·Granted Apr 17, 1990·60 cites·16 claims
- 0794US4920132AQuinoline derivatives and use thereof as antagonists of leukotriene D4RORER PHARMACEUTICAL CORP·Filed 1987·Granted Apr 24, 1990·83 cites·43 claims
- 0892US8030305B2Triazolopyridazines as kinase modulatorsJANSSEN PHARMACEUTICA NV·Filed 2006·Granted Oct 4, 2011·24 cites·18 claims
- 0991US10730826B2Ketone inhibitors of lysine gingipainCORTEXYME INC·Filed 2019·Granted Aug 4, 2020·3 cites·11 claims
- 1091US9809541B2LSD1 inhibitorsMIRATI THERAPEUTICS INC·Filed 2016·Granted Nov 7, 2017·11 cites·62 claims
- 1190US6750225B21,4,5,6-tetrahydropyrazolo-[3,4,-c]-pyridin-7-ones useful as factor Xa inhibitorsBRISTOL MYERS SQUIBB PHARMS CO·Filed 2002·Granted Jun 15, 2004·35 cites·65 claims
- 1290US6602871B2Thrombin or factor Xa inhibitorsBRISTOL MYERS SQUIBB PHARMA CO·Filed 2001·Granted Aug 5, 2003·20 cites·24 claims
- 1390US6271237B1Nitrogen containing heteromatics with ortho-substituted P1s as factor Xa inhabitorsDU PONT PHARM CO·Filed 1998·Granted Aug 7, 2001·57 cites·42 claims
- 1489US8173654B2Triazolopyridazine compoundsLU TIANBAO·Filed 2008·Granted May 8, 2012·21 cites·15 claims
- 1589US5468898ASubstituted naphthylene compounds exhibiting selective leukotriene B4 antagonist activityRHONE POULENC RORER PHARMA·Filed 1991·Granted Nov 21, 1995·34 cites·6 claims
- 1689US4920133AQuinoline derivatives and use thereof as antagonists of leukotriene D4RORER PHARMACEUTICAL CORP·Filed 1987·Granted Apr 24, 1990·54 cites·22 claims
- 1789US4920130AQuinoline derivatives and use thereof as antagonists of leukotriene D4RORER PHARAMCEUTICAL CORP·Filed 1987·Granted Apr 24, 1990·58 cites·22 claims
- 1887US10828373B2Bioorthogonal compositionsTAMBO INC·Filed 2016·Granted Nov 10, 2020·5 cites·23 claims
- 1986US10266542B2EZH2 inhibitorsMIRATI THERAPEUTICS INC·Filed 2018·Granted Apr 23, 2019·6 cites·40 claims
- 2085US11325884B2Ketone inhibitors of lysine gingipainCORTEXYME INC·Filed 2020·Granted May 10, 2022·1 cites·12 claims
- 2184US11059786B2Aminopyridine compounds and methods for the preparation and use thereofCORTEXYME INC·Filed 2019·Granted Jul 13, 2021·2 cites·23 claims
- 2283US2025270162A1Ketone inhibitors of lysine gingipainLIGHTHOUSE PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 2377US10023579B2Pyrrolopyrimidine compounds, use as inhibitors of the kinase LRRK2, and methods for preparation thereofSOUTHERN RES INST·Filed 2016·Granted Jul 17, 2018·2 cites·30 claims
- 2477US7662824B2Acylhydrazones as kinase modulatorsJANSSEN PHARMACEUTICA NV·Filed 2006·Granted Feb 16, 2010·2 cites·12 claims
- 2577US6403583B1Thrombin or factor Xa inhibitorsFiled 1999·Granted Jun 11, 2002·17 cites·27 claims
- 2677US5210208ADisubstituted aryl compounds exhibiting selective leukotriene b4 antagonist activityRHONE POULENC RORER PHARMA·Filed 1990·Granted May 11, 1993·18 cites·20 claims
- 2776US4977162AQuinolinyl-chromone derivatives and use for treatment of hypersensitive ailmentsRORER PHARMACEUTICAL CORP·Filed 1989·Granted Dec 11, 1990·22 cites·23 claims
- 2875US12110263B2Ketone inhibitors of lysine gingipainCORTEXYME INC·Filed 2022·Granted Oct 8, 2024·0 cites·21 claims
- 2974US5939418AIsoxazoline, isothiazoline and pyrazoline factor Xa inhibitorsDU PONT MERCK PHARMA·Filed 1996·Granted Aug 17, 1999·19 cites·12 claims
- 3073US10294235B2Pyrrolopyrimidine compounds, use as inhibitors of the kinase LRRK2, and methods for preparation thereofSOUTHERN RES INST·Filed 2018·Granted May 21, 2019·1 cites·16 claims
- 3172US5232948ASubstituted monocyclic aryl compounds exhibiting selective leukotriene b4 antagonist activityRHONE POULENC RORER PHARMA·Filed 1990·Granted Aug 3, 1993·12 cites·12 claims
- 3269US7196110B2N-substituted tricyclic 3-aminopyrazoles as inhibitors for the treatment of cell proliferative disordersJANSSEN PHAMACEUTICA N V·Filed 2003·Granted Mar 27, 2007·6 cites·37 claims
- 3367US5059610AQuinoline derivatives and their use as antagonists of leukotriene d4RHONE POULENC RORER PHARMA·Filed 1988·Granted Oct 22, 1991·11 cites·43 claims
- 3467US2025049936A1Bioorthogonal compositionsTAMBO INC·Filed 2024·Application pending·0 cites
- 3564US2021340105A1Aminopyridine compounds and methods for the preparation and use thereofCORTEXYME INC·Filed 2021·Application pending·0 cites
- 3663US6060462AElectrophilic peptide analogs as inhibitors of trypsin-like enzymesDU PONT PHARM CO·Filed 1997·Granted May 9, 2000·27 cites·12 claims
- 3763US5028615AQuinoline derivatives as antagonists of leukotriene D4RHONE POULENC RORER PHARMA·Filed 1988·Granted Jul 2, 1991·9 cites·22 claims
- 3862US5925635AN-(amidinophenyl) cyclourea analogs as factor XA inhibitorsDU PONT PHARM CO·Filed 1997·Granted Jul 20, 1999·8 cites·20 claims
- 3961US2021015932A1Bioorthogonal compositionsTAMBO INC·Filed 2020·Application pending·0 cites
- 4059US2013231335A1Inhibitors of polo-like kinaseELAN PHARM INC·Filed 2013·Application pending·0 cites
- 4159US2013331376A1Inhibitors of polo-like kinaseELAN CORP INC·Filed 2013·Application pending·0 cites
- 4256US7816390B2N-substituted tricyclic 3-aminopyrazoles as anti-mitotic tubulin polymerization inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2008·Granted Oct 19, 2010·0 cites·2 claims
- 4356US7795440B2N-substituted tricyclic 1-aminopyrazoles as inhibitors for the treatment of cell proliferative disordersJANSSEN PHARMACEUTICA NV·Filed 2007·Granted Sep 14, 2010·0 cites·2 claims
- 4452US2015126502A1Inhibitors of polo-like kinaseELAN PHARM INC·Filed 2015·Application pending·0 cites
- 4551US10233152B2LSD1 inhibitorsMIRATI THERAPEUTICS INC·Filed 2017·Granted Mar 19, 2019·0 cites·23 claims
- 4651US8541418B2Inhibitors of polo-like kinaseGALEMMO ROBERT A·Filed 2010·Granted Sep 24, 2013·0 cites·14 claims
- 4751US8445503B2Inhibitors of polo-like kinaseGALEMMO ROBERT A·Filed 2010·Granted May 21, 2013·0 cites·9 claims
- 4849US2022204457A1Arginine gingipain inhibitorsCORTEXYME INC·Filed 2020·Application pending·0 cites
- 4949US2009270413A1Di-t-butylphenyl piperazines as calcium channel blockersGALEMMO JR ROBERT·Filed 2009·Application pending·0 cites
- 5048US6521614B1N-(amidinophenyl)cyclourea analogs as factor Xa inhibitorsBRISTOL MYERS SQUIBB PHARMA CO·Filed 1999·Granted Feb 18, 2003·3 cites·48 claims
Showing the top 50 of 64 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Robert A. Galemmo, Jr. files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →